Guilin Sanjin Pharmaceutical Co., Ltd. Profile Avatar - Palmy Investing

Guilin Sanjin Pharmaceutical Co., Ltd.

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; …
Biotechnology
CN, Guilin [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Guilin Sanjin Pharmaceutical Co., Ltd. has no acquisition track records yet.

M&A Deals · History

Guilin Sanjin Pharmaceutical Co., Ltd. has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Biotechnology Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of 002275.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE100000DY9 LEI: - UEI: -
Secondary Listings
002275.SZ has no secondary listings inside our databases.